WorldHeart Will End Its Levacor(R) VAD Program and Will Focus on Developing Its Next-Generation MiFlow(TM) Miniature Ventricular Assist Device
7/29/2011 10:08:46 AM
More...
|
WorldHeart Announces Levacor(R) VAD Implant at Tampa General Hospital; Enrollment in Bridge-to-Transplant Study Continues to be Slow as WorldHeart Makes Refinements to Levacor VAD
1/12/2011 9:54:27 AM
More...
|
WorldHeart Announces Levacor VAD Implant at Jewish Hospital, Louisville
7/6/2010 10:50:48 AM
More...
|
WorldHeart Reports First Quarter 2010 Financial Results
5/18/2010 8:24:39 AM
More...
|
WorldHeart Appoints Dr. John Campbell Woodard as Senior Vice President of Scientific Affairs
5/3/2010 8:42:08 AM
More...
|
WorldHeart Appoints Dr. John Campbell Woodard as Senior Vice President of Scientific Affairs
4/30/2010 11:32:36 AM
More...
|
WorldHeart Appoints New President and CEO
2/9/2009 6:57:42 AM
More...
|
WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD
1/9/2009 7:56:06 AM
More...
|
WorldHeart Receives Favorable Decision to Continue NASDAQ Listing
9/16/2008 11:41:04 AM
More...
|
WorldHeart Announces Consolidation Plan
8/21/2008 7:31:52 AM
More...
|
|